First Time Loading...
A

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 2.35 USD +3.07% Market Closed
Updated: Jun 1, 2023

EV/S
Enterprise Value to Sales

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
=
Enterprise Value
/
Revenue
Current EV/S
ADCT
1.1
Median EV/S
ADCT
1.4
Industry EV/S
Biotechnology
7.5

EV/S History

Statistics
Enterprise Value to Sales

1 Year 3 Years 5 Years
Average 2.5 48.5 29.4
Median 1.7 1.4 N/A
Min 0.9 N/A N/A
Max 6.2 523.9 523.9

History Chart
Enterprise Value to Sales

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
1.7
2-Years Forward
EV/S
1.7
3-Years Forward
EV/S
1.2

EV/S Across Competitors

ADCT Competitors
ADC Therapeutics SA Competitors

All Multiples
EV/S

Relative Valuation Report

View full relative valuation report for ADC Therapeutics SA, which takes into account all ADCT`s valuation multiples.

See Also

Similar Stocks